Literature DB >> 22125111

Dependent behavior in patients with medication-overuse headache.

Jong-Ling Fuh1, Shuu-Jiun Wang.   

Abstract

Two thirds of patients with medication-overuse headache (MOH) fulfilled criteria for dependence on acute symptomatic treatments for pain, not exclusive of psychoactive medications, based on the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders. Several questionnaires have been used to assess dependent behavior in patients with MOH. Findings regarding underlying psychological profiles of dependence and MOH are not consistent. Nevertheless, several neuroimaging, genetic, and neurobiological studies support the existence of the common pathophysiological features of dependence and MOH and suggest a link between them. This review highlights recent studies on the relationship between dependence and MOH. This issue is important because it implies a treatment strategy in managing patients with MOH by providing the treatment of dependence.

Entities:  

Mesh:

Year:  2012        PMID: 22125111     DOI: 10.1007/s11916-011-0240-0

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  47 in total

Review 1.  What is the role of dependence-related behavior in medication-overuse headache?

Authors:  Françoise Radat; Michel Lanteri-Minet
Journal:  Headache       Date:  2010-08-27       Impact factor: 5.887

2.  Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey.

Authors:  Joel Swendsen; Kevin P Conway; Louisa Degenhardt; Meyer Glantz; Robert Jin; Kathleen R Merikangas; Nancy Sampson; Ronald C Kessler
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

3.  Medication overuse headache: type I and type II.

Authors:  J R Saper; A E Lake
Journal:  Cephalalgia       Date:  2006-10       Impact factor: 6.292

4.  A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse.

Authors:  S Cevoli; M Mochi; C Scapoli; N Marzocchi; G Pierangeli; L A Pini; P Cortelli; P Montagna
Journal:  Eur J Neurol       Date:  2006-09       Impact factor: 6.089

Review 5.  Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.

Authors:  Ian D Meng; David Dodick; Michael H Ossipov; Frank Porreca
Journal:  Cephalalgia       Date:  2011-03-28       Impact factor: 6.292

6.  Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000.

Authors:  Albina R Torres; Martin J Prince; Paul E Bebbington; Dinesh Bhugra; Traolach S Brugha; Michael Farrell; Rachel Jenkins; Glyn Lewis; Howard Meltzer; Nicola Singleton
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

7.  The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache.

Authors:  Christofer Lundqvist; Kjersti Aaseth; Ragnhild Berling Grande; Jūrate Saltyte Benth; Michael Bjørn Russell
Journal:  Pain       Date:  2010-01-13       Impact factor: 6.961

Review 8.  Medication-overuse headache: a worldwide problem.

Authors:  Hans-Christoph Diener; Volker Limmroth
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

Review 9.  Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?

Authors:  Ethan B Russo
Journal:  Neuro Endocrinol Lett       Date:  2004 Feb-Apr       Impact factor: 0.765

10.  How should we revise diagnostic criteria for substance use disorders in the DSM-V?

Authors:  Christopher S Martin; Tammy Chung; James W Langenbucher
Journal:  J Abnorm Psychol       Date:  2008-08
View more
  11 in total

Review 1.  Medication-overuse headache: a perspective review.

Authors:  Maria Lurenda Westergaard; Signe Bruun Munksgaard; Lars Bendtsen; Rigmor Højland Jensen
Journal:  Ther Adv Drug Saf       Date:  2016-06-30

Review 2.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

3.  Drug-dependence behaviour and outcome of medication-overuse headache after treatment.

Authors:  Ilenia Corbelli; Stefano Caproni; Paolo Eusebi; Paola Sarchielli
Journal:  J Headache Pain       Date:  2012-10-18       Impact factor: 7.277

Review 4.  Behavioral therapy for chronic migraine.

Authors:  Francesca Pistoia; Simona Sacco; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2013-01

Review 5.  Neuroimaging Findings in Patients with Medication Overuse Headache.

Authors:  Tzu-Hsien Lai; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2018-01-16

Review 6.  Medication-overuse headache: a review.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  J Pain Res       Date:  2014-06-26       Impact factor: 3.133

7.  Severity of Analgesic Dependence and Medication-overuse Headache.

Authors:  Christofer Lundqvist; Michael Gossop; Michael Bjørn Russell; Jørund Straand; Espen Saxhaug Kristoffersen
Journal:  J Addict Med       Date:  2019 Sep/Oct       Impact factor: 3.702

8.  The Ruminative Thought Style with Associated Anxiety Influences the Occurrence of Medication-Overuse Headache.

Authors:  Marina Ljubisavljevic; Aleksandra Ignjatovic; Srdjan Ljubisavljevic
Journal:  J Clin Neurol       Date:  2021-07       Impact factor: 3.077

9.  HDAC3 role in medication consumption in medication overuse headache patients: a pilot study.

Authors:  Claudia Pisanu; Stefano Caproni; Donatella Congiu; Letizia M Cupini; Alessio Squassina; George P Patrinos; Ilenia Corbelli; Paolo Calabresi; Maria Del Zompo; Paola Sarchielli
Journal:  Hum Genomics       Date:  2015-11-05       Impact factor: 4.639

10.  Nucleus accumbens functional connectivity discriminates medication-overuse headache.

Authors:  D M Torta; T Costa; E Luda; M G Barisone; P Palmisano; S Duca; G Geminiani; F Cauda
Journal:  Neuroimage Clin       Date:  2016-05-14       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.